CAS: 138-37-4; 4-(Aminomethyl)Benzenesulfonamide Hydrochloride

该化合物是一种有机化合物,其特征为磺酰胺功能组和附属于苯环的氨基化合物,该化合物看起来像白色的脱白晶晶状固体,在水中可溶解,由于存在极性功能组,这在许多全氟辛烷磺酸衍生物中都是典型的.该化合物在药用化学中具有应用性,特别是作为药物合成的中间体和潜在的抗菌剂.该盐形式表明它是盐,在水溶溶溶液中增强了其稳定性和溶解性.该化合物的结构允许氢结合,有助于其溶解性和再活性.此外,该化合物还可能展示生物活动,使其在药物开发和研究中引起兴趣.应当参考安全数据,以便处理和接触准则,如所有化学物质一样.

结构式图片

相似化合物

1203655-71-3 13009-99-9 7761-27-5

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7109377-B2
    优先权日:1996-10-16
    标 题:Synthesis of combinatorial libraries of compounds reminiscent of natural products
    发明人:SCHREIBER STUART L; SHAIR MATTHEW D; TAN DEREK S; FOLEY MICHAEL A; STOCKWELL BRENT R
    权利人:HARVARD COLLEGE
    摘要:The present invention provides complex compounds reminiscent of natural products and libraries thereof, as well as methods for their production. The inventive compounds and libraries of compounds are reminiscent of natural products in that they contain one or more stereocenters, and a high density and diversity of functionality. In general, the inventive libraries are synthesized from diversifiable scaffold structures, which are synthesized from readily available or easily synthesizable template structures. In certain embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from a shikimic acid based epoxyol template. In other embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from the pyridine-based template isonicotinamide. The present invention also provides a novel ortho-nitrobenzyl photolinker and a method for its synthesis. Furthermore, the present invention provides methods and kits for determining one or more biological activities of members of the inventive libraries. Additionally, the present invention provides pharmaceutical compositions containing one or more library members.

    专利号:WO-2024127343-A1
    优先权日:2022-12-16
    标 题 :Inhibitors of ectonucleotide pyrophosphatase / phosphodiesterase 1 (enpp-1)
    发明人:RAMANARAYANAN GANAPATHY BHOTLA VENKATA; SARAVANAN PERUMAL; SARAVANAN VADIVELU; NAGARAJ KULKARNI
    权利人:SRAVATHI AI TECH PRIVATE LIMITED
    摘要:The present invention discloses a novel type of highly potent ENPP-1 inhibitors for the treatment of various diseases particularly, cancer. The compounds of the invention have tail, core, and zinc binding portions (ZBP), where the key feature includes positioning of a sulfoximine-type moiety and an amino nitrogen atom specified as G 1 or G 2 fragment in a saturated cyclic ring in the core part. Synthesis of compounds of formula (1), pharmaceutical compositions and use thereof are also disclosed.

    专利号:US-2003138490-A1
    优先权日:2001-09-08
    标 题 :Synthesis and uses of polymer gel nanoparticle networks
    发明人:HU ZHIBING; LU XIHUA; GAO JUN; PONDER BILL C; JOHN JOHN ST; MORO DANIEL G
    摘要:Disclosed is a new class of nanostructured polymeric materials comprising polymer gel nanoparticles that are covalently bonded through functional groups on the surfaces of neighboring particles. These nanoparticles may be prepared as suspensions in an aqueous or, non-aqueous environment. These gels have two unique and different structural networks; the primary network comprises crosslinked polymer chains in each individual particle, while the secondary network is a system of crosslinked nanoparticles. Particular polymer gel nanoparticle network compositions disclosed herein may function as carriers for controlled delivery of pharmaceuticals or other chemical agents, gel sensors and other commercial applications.

    专利号:US-2003082830-A1
    优先权日:1996-10-16
    标 题:Synthesis of combinatorial libraries of compounds reminiscent of natural products

    专利号:US-2007203079-A1
    优先权日:2005-11-21
    标题:Methods of using small molecule compounds for neuroprotection
    发明人:CALDWELL GUY A; CALDWELL KIM A; CAO SONGSONG
    权利人:CALDWELL GUY A; CALDWELL KIM A; CAO SONGSONG
    摘要:Methods are provided for preventing neurodegeneration and neuronal loss by administering compositions comprising small molecule compounds with the effect of preventing neurodegeneration and neuronal loss. In one aspect of the invention, the methods and compositions are also useful for treating neurodegenerative diseases. Small molecule compounds provide an important treatment option because of their stability, ease of use in both manufacture and formulation, ease of administration, and patient compliance. The small molecule compound compositions of the present invention may include topoisomerase II inhibitors, bacterial transpeptidase inhibitors, calcium channel antagonists, cyclooxygenase inhibitors, folic acid synthesis inhibitors, or sodium channel blockers and functional analogues thereof that have an effect on neurodegeneration. The compositions of the present invention may be administered prophylactically before the onset of clinical symptoms or after clinical symptoms of a neurodegenerative disease have manifested.

    专利号:WO-0006525-A9
    优先权日:1998-07-25
    标题:Synthesis of combinatorial libraries of compounds reminiscent of natural products
    武汉润泽伟业科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:02750779735👤
    ⚠️参考联系方式
    邮件:runzeweiye999@163.com
    销售经理: 徐海涛经理
    联系电话:02750779735
    手机号码: 15172337137
    传真号码: 02750779735
    QQ号:940329747
    硚口区
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Mendelson JA. Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue. Prehosp Disaster Med. 2001 Jul-Sep;16(3):172-4. Review.

    合成参考文献


    参考文献:10.1038/ncomms14193|10.1038/ncomms15273
    摘要:Pegoraro S, Duffey M, Otto TD, Wang Y, Rösemann R, Baumgartner R, Fehler SK, Lucantoni L, Avery VM, Moreno-Sabater A, Mazier D, Vial HJ, Strobl S, Sanchez CP, Lanzer M. Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria. Nature Communications. 2017 Apr 06;8(1):15273. doi: 10.1038/ncomms15273.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知